⚠️ Important All products on our website are intended solely for laboratory and research purposes. The information provided for each product is for educational and informational purposes only. These products are not intended for use in or on humans or animals. They are recommended to be handled only by qualified professionals in a controlled environment.

Click to enlarge

Retatrutide | 6, 12, 20, 40mg

Stabilized Pre-Mixed Pen

Price range: $169.00 through $439.00

Quantity	Price	Discount
3-5	$160.55	5%
6-9	$157.17	7%
10+	$152.10	10%

We can fulfill bulk orders now

Our team will respond to your inquiry within the same day.

Size

6 mg

12 mg

20 mg

40 mg

Clear

What is MSSPT technology?

How We Keep Peptides Stable Inside a Pen
Our MSSPT™ (Molecular Structure Stabilization Process Technology) keeps every peptide molecule intact and active—from production to the moment you click the pen.

Why it matters: Peptides are sensitive to heat, light, oxygen, pH swings, and shaking. MSSPT™ is our end‑to‑end method to protect them at every stage.

The MSSPT™ Playbook:

Make the Molecule Tougher: Smart chemistry tweaks and protective groups reduce weak spots.
Build the Right Microenvironment: Buffers, antioxidants, and stabilizers actively prevent degradation.
Optimize Storage & Process: Freeze-drying, controlled humidity, and temperature safeguards ensure long-term stability.
Engineer the Pen as a Shield: Light/oxygen barriers, desiccants, and low-shear pathways protect during use.
Prove It With Data: Rigorous stability studies and analytics guarantee potency and safety.

What This Means For You: Reliable potency, convenient multi-peptide delivery, and consistent safety dose after dose.

▼ Expand

Research-Grade Quality

Every pen is manufactured under strict quality control for consistent and reliable lab use.

Stabilized Pre-Mixed Formula

No reconstitution required – optimized for convenience and accuracy in research.

Verified Source & Purity

Third-party tested for purity and identity to meet research standards.

Temperature-Controlled Shipping

Shipped in insulated packaging with cold packs to maintain optimal temperature. Every order is tracked to ensure safe and timely delivery.

Proper storage

To guarantee the highest quality of our research peptides, we prioritize proper delivery and storage conditions. Every order is shipped in specialized cooling boxes designed to maintain the necessary temperature throughout transit, ensuring that your peptides arrive in optimal condition.

Upon receiving your peptides, proper storage is essential to preserve their stability and potency. We recommend keeping them refrigerated at a temperature between 2°C and 8°C. This safeguards their integrity, allowing them to maintain their effectiveness throughout their shelf life.

For research use only.

Shipping details

Fast and secure shipping of your order with FedEx, ensuring the highest quality and reliability at every step.

Order Processing & Packaging

Once your payment is confirmed via bank transfer or debit/credit card, we ship your order on the next business day.
All orders are carefully packaged in temperature-controlled cooling boxes to maintain peptide integrity during transit.

Delivery Timeframe

Standard U.S. delivery time: 1 to 3 business days.
Orders are shipped exclusively via FedEx for a fast, safe, and reliable delivery experience.

Tracking & Order Confirmation

Once your payment is processed and order is shipped, you will receive an email confirmation with your tracking number.
You can track your order in real time using the FedEx tracking page.

How does the pen work?

The Peptide Pen is an advanced, pre-mixed device designed for accurate dosing in research applications. This ready-to-use pen eliminates the need for mixing, ensuring efficiency and reliability in every use.

Key Features of the Peptide Pen

✔ Pre-Mixed & Ready-to-Use – No need for dilution or manual preparation.
✔ Precision Dosing – Each pen is pre-calibrated for consistent and accurate measurement.
✔ Sterile & Secure – Manufactured in a controlled laboratory environment and packaged under strict sterile conditions to maintain purity and stability.
✔ User-Friendly Design – Ergonomic and easy-to-handle, making research more efficient.

How to Use the Peptide Pen?

1️⃣ Attach the needle – Secure it by twisting onto the pen until firmly in place.
2️⃣ Set the precise dose – Adjust the dosage dial by rotating the regulator to the desired units (ranging from 0 to 60).
3️⃣ Administer as per research protocols – Ensuring controlled and reproducible application.
4️⃣ Proper Storage – Keep the pen refrigerated between 2°C and 8°C to maintain peptide integrity and stability.

⚠ Note: Our peptides are for research use only and are not intended for human consumption.

What is Retatrutide?

Retatrutide is a peptide that combines triple receptor activation on GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This combination provides an exceptionally effective approach to treating complex metabolic disorders, including type 2 diabetes, obesity, and associated cardiovascular diseases.

Unlike traditional peptide agonists that target a single receptor, Retatrutide integrates three metabolic regulation pathways, offering greater efficacy and improved tolerability. The peptide is administered via subcutaneous injection and has an extended duration of action, allowing for once-weekly administration. This feature makes it particularly convenient for researchers working in the fields of metabolic diseases and regenerative medicine.

Beyond its role in managing type 2 diabetes and obesity, Retatrutide is being investigated for expanded applications, including reducing inflammation, improving lipid profiles, and preventing cardiovascular complications.

Retatrutide has been developed to provide significant benefits in blood sugar management, weight reduction, and overall metabolic health improvement. Due to its triple mechanism of action, this peptide offers unique research opportunities in the medical field.

How does Retatrutide work?

Retatrutide functions by activating three key receptors—GLP-1, GIP, and glucagon receptors—responsible for metabolic regulation. This triple activation leads to synergistic effects, encompassing blood sugar control, appetite management, and fat loss promotion. Here’s how the individual mechanisms work:

GLP-1 receptors: Activation of these receptors stimulates insulin secretion, helping to lower blood sugar levels. GLP-1 also slows gastric emptying, leading to prolonged satiety and reduced calorie intake. Additionally, this pathway suppresses glucagon secretion, a hormone that increases glucose production by the liver.
GIP receptors: GIP receptor activation complements GLP-1 action by enhancing insulin response and improving insulin sensitivity in peripheral tissues. Furthermore, GIP receptor activation reduces inflammatory processes and improves lipid metabolism by lowering triglycerides and LDL cholesterol.
Glucagon receptors: Activation of glucagon receptors stimulates lipolysis (fat breakdown) and thermogenesis, leading to a reduction in fat tissue. This action is particularly valuable for patients with obesity and for research on energy balance management.

Through these mechanisms, Retatrutide achieves a comprehensive approach to metabolic health, simultaneously improving glycemic control, promoting weight loss, and providing protection against cardiovascular risks.

Research on Retatrutide

Retatrutide has been the subject of numerous clinical and preclinical studies, confirming its efficacy and safety in managing metabolic disorders. Ongoing Retatrutide trials, including phase 2 studies, provide valuable insights into its effects on obesity, type 2 diabetes, lipid metabolism, and inflammation.

Retatrutide Clinical Trials and Ongoing Studies

Retatrutide has been tested in various clinical trials, evaluating its effectiveness in metabolic disease management. Researchers continue to explore its full potential in blood sugar control, weight loss, and cardiovascular health.

How Does Retatrutide Work in Clinical Studies?
Retatrutide’s triple receptor activation mechanism targets GLP-1, GIP, and glucagon receptors, allowing for enhanced weight loss, improved insulin sensitivity, and cardiovascular protection. Ongoing clinical research focuses on understanding its long-term metabolic effects and fat oxidation potential.
Retatrutide Phase 2 Results Overview
Recent phase 2 clinical trials have demonstrated significant weight loss and improved glycemic control. Participants experienced sustained reductions in body fat, better insulin sensitivity, and enhanced lipid metabolism.

Retatrutide for Obesity and Type 2 Diabetes Research

Type 2 Diabetes Control

Clinical studies show that Retatrutide significantly reduces HbA1c (glycated hemoglobin) levels in patients with type 2 diabetes. This enhances long-term blood sugar management. Compared to other GLP-1 receptor agonists, Retatrutide provides superior glycemic control, thanks to its triple receptor activation.

Weight Loss Benefits

In trials conducted on obese patients, Retatrutide demonstrated remarkable weight loss effects. The peptide works by:

Suppressing appetite
Increasing thermogenesis (heat production for fat burning)
Stimulating lipolysis (fat breakdown)

These mechanisms make Retatrutide a powerful tool for weight management research.

Metabolic and Cardiovascular Benefits of Retatrutide

Improvement in Lipid Profile

Studies indicate that Retatrutide significantly lowers triglycerides and LDL cholesterol while increasing HDL (good cholesterol). These changes contribute to a lower risk of cardiovascular diseases, including atherosclerosis and heart disease.

Anti-Inflammatory Effects

Additional research suggests that Retatrutide reduces inflammatory markers, making it valuable for chronic inflammation studies. It may have applications in metabolic syndrome research and autoimmune-related conditions.

Long-Term Safety and Future Research on Retatrutide

Retatrutide has demonstrated good tolerability in long-term studies. Adverse effects are generally mild and temporary, making it a promising candidate for continued research in metabolic and weight loss treatments.

Retatrutide – Structural and Molecular Properties

Retatrutide is a multi-receptor peptide agonist, designed to interact with GLP-1, GIP, and glucagon receptors. Its hybrid peptide sequence is engineered to optimize receptor activation and metabolic regulation, particularly in weight loss and energy balance research.

The stabilized helical structure of Retatrutide allows for enhanced receptor binding and extended biological half-life, reducing the need for frequent administration. Unlike other GLP-1 receptor agonists, Retatrutide’s dual and triple receptor activity contributes to its unique metabolic effects, including enhanced lipolysis, appetite regulation, and improved glucose homeostasis.

Its engineered structure enhances receptor specificity, making it a valuable peptide in obesity and metabolic disorder research.

History and Development of Retatrutide

Retatrutide was developed as part of a new generation of peptide therapies that combine multi-target receptor activation. Its development began with the goal of overcoming the limitations of single-target peptide agonists by creating a molecule with triple action.

In preclinical and clinical trials, Retatrutide has demonstrated significant advantages in terms of efficacy and duration of action. Today, it is the focus of extensive research aimed at expanding its applications in the treatment of metabolic disorders, cardiovascular risks, and conditions related to excess weight.

Benefits and Potential Applications of Retatrutide

Retatrutide offers a wide range of benefits, making it a valuable tool for research and therapeutic applications. Here are its key advantages and potential areas of application:

Blood Sugar Control: Thanks to its triple receptor activation, Retatrutide provides exceptional blood sugar control in patients with type 2 diabetes. It enhances insulin secretion, improves insulin sensitivity, and reduces glucagon levels.
Weight Reduction: Retatrutide has been proven to reduce body fat by suppressing appetite and stimulating lipolysis. This makes it highly effective in the treatment of obesity and its related complications.
Cardiovascular Protection: Retatrutide improves the lipid profile by reducing triglycerides and LDL cholesterol. Additionally, it lowers inflammatory markers, helping protect against cardiovascular diseases.
Metabolic Research: Due to its triple activation, Retatrutide is a powerful tool for studies on energy balance, lipid metabolism, and mechanisms related to metabolic syndrome.
Applications in Chronic Diseases: Beyond diabetes and obesity, Retatrutide may be explored for potential benefits in chronic inflammatory conditions and neurodegenerative diseases.
Improvement in Quality of Life: By managing weight and metabolic parameters, Retatrutide contributes to increased energy levels, reduced fatigue, and overall health improvement.

These characteristics position Retatrutide as an innovative and promising peptide for managing complex metabolic and related disorders.

Possible Side Effects of Retatrutide

Although Retatrutide is well tolerated in clinical studies, it is important to note some potential side effects that may occur during its administration. These are typically mild to moderate and temporary. The main side effects include:

Gastrointestinal Symptoms: Nausea, vomiting, diarrhea, and constipation are among the most common adverse reactions. These symptoms usually occur in the early stages of therapy and diminish as the body adapts to the treatment.
Headache: Some users report headaches, which are often temporary and observed at the beginning of therapy.
Mild Increase in Heart Rate: Retatrutide may lead to a slight increase in heart rate, especially during the initial stages of therapy.
Local Injection Site Reactions: Redness, itching, or mild swelling at the injection site may occur. These reactions are typically short-lived and do not require specific treatment.
Fatigue and Weakness: Some users report feelings of fatigue or weakness, which usually subside with continued use of the medication.

These side effects are generally temporary and do not necessitate discontinuation of the study. In case of more severe reactions or persistent symptoms, consultation with a specialist is recommended.

Retatrutide vs Tirzepatide: Key Differences in Metabolic Research

Retatrutide and Tirzepatide are both next-generation peptides targeting metabolic disorders, but they differ in their receptor activation and potential applications. Tirzepatide acts as a dual agonist on GLP-1 and GIP receptors, while Retatrutide introduces a triple receptor activation mechanism, also engaging glucagon receptors. This additional pathway may enhance fat metabolism, thermogenesis, and energy balance, making Retatrutide a promising candidate in weight management and metabolic studies. Ongoing research continues to explore the distinct advantages of each peptide in glucose regulation, obesity treatment, and cardiovascular health.